uniQure N.V. (NASDAQ: QURE) started the day on Wednesday, with a price decrease of -3.46% at $5.02, before settling in for the price of $5.20 at the close. Taking a more long-term approach, QURE posted a 52-week range of $4.76-$22.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 302.35% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -22.59%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.53%. This publicly-traded company’s shares outstanding now amounts to $47.83 million, simultaneously with a float of $42.55 million. The organization now has a market capitalization sitting at $240.16 million. At the time of writing, stock’s 50-day Moving Average stood at $5.49, while the 200-day Moving Average is $7.16.
uniQure N.V. (QURE) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. uniQure N.V.’s current insider ownership accounts for 11.05%, in contrast to 79.16% institutional ownership. According to the most recent insider trade that took place on Feb 26 ’24, this organization’s CEO, Managing Director sold 27,904 shares at the rate of 6.35, making the entire transaction reach 177,190 in total value, affecting insider ownership by 440,839. Preceding that transaction, on Feb 26 ’24, Company’s Chief Financial Officer sold 15,906 for 6.38, making the whole transaction’s value amount to 101,480. This particular insider is now the holder of 116,948 in total.
uniQure N.V. (QURE) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2023, the organization reported -$1.53 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$1.45) by -$0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.24 per share during the current fiscal year.
uniQure N.V.’s EPS increase for this current 12-month fiscal period is 33.53% and is forecasted to reach -3.86 in the upcoming year.
uniQure N.V. (NASDAQ: QURE) Trading Performance Indicators
Let’s observe the current performance indicators for uniQure N.V. (QURE). It’s Quick Ratio in the last reported quarter now stands at 8.68. The Stock has managed to achieve an average true range (ATR) of 0.28. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 15.16.
In the same vein, QURE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.47, a figure that is expected to reach -1.28 in the next quarter, and analysts are predicting that it will be -3.86 at the market close of one year from today.
Technical Analysis of uniQure N.V. (QURE)
If we take a close look at the recent performances of uniQure N.V. (NASDAQ: QURE), its last 5-days Average volume was 0.66 million that shows plunge from its year to date volume of 1.03 million. During the previous 9 days, stock’s Stochastic %D was recorded 35.18% While, its Average True Range was 0.26.
Raw Stochastic average of uniQure N.V. (QURE) in the period of the previous 100 days is set at 6.67%, which indicates a major fall in contrast to 13.21% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 43.72% that was lower than 70.19% volatility it exhibited in the past 100-days period.
